Please provide your email address to receive an email when new articles are posted on . The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of ...
Please provide your email address to receive an email when new articles are posted on . An updated version of the Xpert MTB/RIF assay, which includes new gene target ...
In low-incidence, high-resource settings, Xpert Mycobacterium Tuberculosis/Rifampicin Ultra (Xpert MTB/RIF Ultra [Xpert-Ultra]) testing, an automated nucleic acid ...
The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert MTB/RIF Ultra. It is the first test for TB diagnosis and antibiotic ...
Prospective multicentre study highlights the potential of the Xpert MTB/Ultra stool test for diagnosing tuberculosis in people living with HIV “People living with HIV are at higher risk of developing ...
Cepheid has supported TB testing worldwide for over 15 years. Xpert MTB/RIF, released in 2009 in collaboration with the Foundation for Innovative New Diagnostics (FIND), was a first-of-its-kind ...
The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...
GENEVA and SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which ...
SUNNYVALE, Calif., Oct. 28, 2025 /PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results